Bayer Aktiengesellschaft (BAYN.F)
Makes medicines, over-the-counter health products, and agricultural crop protection solutions
47.17+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+66.9%
The outlook
Bayer's stock is trading above both its 50- and 200-day moving averages, sitting about three-quarters of the way up from its 52-week low. Analysts lean bullish with a Buy consensus, and their average price target sits roughly 16% above the current price. The overall data shows a positive technical position with solid analyst support.
What’s behind the score
Analyst consensusBuy — 1.8 avg of 18 analysts
Price trendAbove its 50- & 200-day averages
52-week range77% of the way from its 52-week low to high
Price targetAvg target +16% vs current price
Analyst price target
~12-month · 18 analysts54.92average target+16.4% vs now
Now 47.17
Low 46.00High 65.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$46.34B
52-wk high
53.74
52-wk low
24.89
50-day avg
42.50
200-day avg
38.76
Trailing P/E
—